A prognostic method and kit for the identification of the risk of development of albuminuria, risk of renal damage and cardiovascular risk in a hipperenso human subject (Machine-translation by Google Translate, not legally binding)

摘要

A prognostic method and kit to identify the risk of albuminuria development, risk of kidney damage and cardiovascular risk in a hypertensive human subject. The method comprises the evaluation of the urine concentration of at least one compound selected from glutamate, glycerate, guanidoacetate, pantothenate, oxaloacetate, 3-ureidopropionate, 3-hydroxybutyrate, malate and pyruvate, the determination of whether at least one of the markers it is above or below the standard values in healthy subjects, in which said markers are the concentration of compounds and panels composed of several compounds, and the identification of risks in said human subject. (Machine-translation by Google Translate, not legally binding)